GlaxoSmithKline PLC ADR Cash Flow Reinvestment Rate
GlaxoSmithKline PLC ADR cash flow reinvestment rate. GlaxoSmithKline PLC ADR (GSK) has a Cash Flow Reinvestment Rate of 0.13x as of June 2026, reinvesting $328.95 Million (capex $328.95 Million ) from operating cash flow of $2.54 Billion. Explore GSK operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of GlaxoSmithKline PLC ADR (1990–2025)
Cash flow reinvestment rate of GlaxoSmithKline PLC ADR from 1990 to 2025. Historical reinvestment intensity for GlaxoSmithKline PLC ADR across 36 annual periods. Explore GSK capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
GlaxoSmithKline PLC ADR Cash Flow Reinvestment Rate by Year (1990–2025)
GlaxoSmithKline PLC ADR cash flow reinvestment rate by year from 1990 to 2025. Year-by-year capital reinvestment analysis for GlaxoSmithKline PLC ADR. For the full cash flow conversion analysis, see cash flow conversion of GlaxoSmithKline PLC ADR.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $1.33 Billion | $7.14 Billion | $1.32 Billion | ▼ -71.0% |
| 2024 | 0.64x | $4.21 Billion | $6.55 Billion | $2.98 Billion | ▲ +57.0% |
| 2023 | 0.41x | $3.23 Billion | $7.89 Billion | $1.63 Billion | ▼ -72.5% |
| 2022 | 1.49x | $11.03 Billion | $7.40 Billion | $2.26 Billion | ▲ +262.9% |
| 2021 | 0.41x | $3.27 Billion | $7.95 Billion | $2.93 Billion | ▼ -21.2% |
| 2020 | 0.52x | $4.40 Billion | $8.44 Billion | $2.24 Billion | ▼ -44.4% |
| 2019 | 0.94x | $7.52 Billion | $8.02 Billion | $2.16 Billion | ▲ +135.7% |
| 2018 | 0.40x | $3.35 Billion | $8.42 Billion | $1.80 Billion | ▼ -24.5% |
| 2017 | 0.53x | $3.65 Billion | $6.92 Billion | $2.20 Billion | ▼ -5.5% |
| 2016 | 0.56x | $3.62 Billion | $6.50 Billion | $2.35 Billion | ▼ -86.1% |
| 2015 | 4.02x | $10.32 Billion | $2.57 Billion | $1.90 Billion | ▲ +1013.8% |
| 2014 | 0.36x | $1.87 Billion | $5.18 Billion | $1.75 Billion | ▲ +26.2% |
| 2013 | 0.29x | $2.06 Billion | $7.22 Billion | $1.70 Billion | ▼ -17.8% |
| 2012 | 0.35x | $1.52 Billion | $4.38 Billion | $1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | $1.33 Billion | $6.25 Billion | $1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | $1.64 Billion | $6.80 Billion | $1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | $1.87 Billion | $7.84 Billion | $1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | $2.07 Billion | $7.31 Billion | $2.07 Billion | ▼ -18.6% |
| 2007 | 0.35x | $2.14 Billion | $6.17 Billion | $2.14 Billion | ▼ -10.9% |
| 2006 | 0.39x | $1.59 Billion | $4.08 Billion | $1.59 Billion | ▲ +104.6% |
| 2005 | 0.19x | $1.18 Billion | $6.20 Billion | $1.18 Billion | ▲ +269.3% |
| 2004 | 0.05x | $255.00 Million | $4.94 Billion | $255.00 Million | ▼ -76.4% |
| 2003 | 0.22x | $1.06 Billion | $4.85 Billion | $1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | $1.23 Billion | $3.06 Billion | $1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | $1.12 Billion | $4.61 Billion | $1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | $1.10 Billion | $1.85 Billion | $1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | $597.00 Million | $510.00 Million | $597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | $475.00 Million | $410.00 Million | $475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | $415.00 Million | $615.00 Million | $415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | $401.00 Million | $849.00 Million | $401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | $684.00 Million | $1.25 Billion | $684.00 Million | ▲ +175.5% |
| 1994 | 0.20x | $485.59 Million | $2.45 Billion | $485.59 Million | ▼ -63.7% |
| 1993 | 0.55x | $575.00 Million | $1.05 Billion | $575.00 Million | ▼ -16.7% |
| 1992 | 0.66x | $608.00 Million | $927.00 Million | $608.00 Million | ▼ -27.5% |
| 1991 | 0.90x | $594.00 Million | $657.00 Million | $594.00 Million | ▼ -8.2% |
| 1990 | 0.99x | $606.00 Million | $615.00 Million | $606.00 Million | — |